What is the Fiscal Year for Veloxis Pharmaceuticals?
Date: November 13, 2026
Veloxis Pharmaceuticals's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Cary, North Carolina
Industry
Pharmaceutical Manufacturing
Stock Symbol
VELO
Website
https://www.aktx.com/enDescription
Veloxis Pharmaceuticals, Calliditas Therapeutics and Aicuris have come together as Asahi Kasei Therapeutics. Asahi Kasei Therapeutics, the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, is a commercial-stage company committed to positively impacting health by expanding therapeutic options that improve the lives of patients around the world.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Veloxis Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.